Puretech Health Plc (PRTCL)

135.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 150.80
  • 52 Week Low: 101.60
  • Currency: UK Pounds
  • Shares Issued: 237.39m
  • Volume: 32,659
  • Market Cap: £320.47m

PRTCL Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Key Personnel

Independent Non-Executive Director: John LaMattina
Independent Non-Executive Director: Michele Holcomb
Independent Non-Executive Director: Kiran Mazumdar Shaw
Interim CEO: Robert Lyne
Interim Chairman: Sharon Barber-Lui
Non-Executive Dir: H. Robert Horvitz, Robert Langer

Contact Details

Address: 6 Tide St Ste 400, Boston, United States, MA, 02210
Phone: +1 617 482 2333
Website: http://www.puretechhealth.com

Listings

Overseas Listings: LSE:PRTC
ISIN: GB00BY2Z0H74

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

PRTCL Market Data

Currency UK Pounds
Share Price 135.00p
Change Today 1.00p
% Change 0.75 %
52 Week High 150.80
52 Week Low 101.60
Volume 32,659
Shares Issued 237.39m
Market Cap £320.47m

Trades for 15-Jan-2026

Time Volume / Share Price
13:19 500 @ 135.00p
13:14 292 @ 135.80p
13:14 915 @ 135.80p
13:14 1,019 @ 136.00p
13:14 3,802 @ 136.00p

Top of Page